Target intelligence / Profile preview

SFTPD antisense RNA 1 (SFTPD-AS1)

Target
SFTPD-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

SFTPD antisense RNA 1 (SFTPD-AS1) is annotated as a long non-coding RNA transcribed from the locus opposite the SFTPD protein-coding gene, which encodes surfactant protein D. Antisense RNAs typically function in regulating expression of their sense gene through RNA-RNA interactions, epigenetic modification, or chromatin remodeling, but there is currently no specific published data describing the biological function, expression pattern, disease relevance, or clinical utility of SFTPD-AS1. Canonical knowledge and public databases recognize the existence of this transcript, but its precise molecular and clinical role is not established, and it is not considered a drug target or established biomarker at this time.

02

Mechanism of action

not applicable

03

Biological functions

Regulation of gene expression (general function of antisense RNAs)Specific function for SFTPD-AS1 uncharacterized (no direct data found)
04

Disease associations

Not established for SFTPD-AS1General class implication: Antisense RNAs are sometimes implicated in cancer, fibrosis, and other conditions via gene regulation

Beyond the preview

Go deeper on SFTPD antisense RNA 1 (SFTPD-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SFTPD antisense RNA 1 (SFTPD-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call